NCT07430436

Brief Summary

The goal of this clinical trial is to examine the effectiveness of Adaptive Karate Training (AKT) in improving self-regulation and daily function in children with ADHD, exploring the underlying mechanisms. The main questions it aims to answer are:

  1. 1.Is the AKT more effective than no karate training in enhancing functional performance, self-regulation and school QoL?
  2. 2.Are poorer executive functions, emotional regulation, and sensory processing associated with higher gains?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Feb 2026Dec 2027

First Submitted

Initial submission to the registry

January 26, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

February 26, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

January 26, 2026

Last Update Submit

February 23, 2026

Conditions

Keywords

Attention Deficit Hyperactivity DisorderSelf RegulationKarateOccupational TherapyParticipation

Outcome Measures

Primary Outcomes (2)

  • Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure (COPM) is a client-centered outcome measure for individuals to identify and prioritize everyday issues that restrict their participation in everyday living. Participants will define three goals, and rate their current performance \& satisfaction for each goal using a 10-point scale. Higher scores indicate better outcomes.

    changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • Total number of participants completing the intervention

    Total number of participants completing the AKT, 15 sessions.

    completing 15 sessions over eight weeks.

Secondary Outcomes (11)

  • Dual Tasking gait analysis

    changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • Behavioral Assessment of the Dysexecutive Syndrome for Children (BADS-zoo map)

    Changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • The Birthday Task Assessment

    Changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • The The Preschool Executive Task Assessment (PETA)

    Changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • Behavior Rating Inventory of Executive function (BRIEF)

    Changes in scores between pre (T1-week 0) to T2 (8 weeks later), to T3 (8 weeks post T2).

  • +6 more secondary outcomes

Study Arms (2)

Adapted karate training

EXPERIMENTAL

Participants will undergo adapted karate training practices, 2 hours weekly for two months, with a karate instructor and an Occupational Therapist specializing in neurodevelopmental disorders, including ADHD.

Other: Adapted karate training

No intervention

NO INTERVENTION

This group will receive no intervention.

Interventions

Participants will undergo adapted karate training practices, 2 hours weekly for two months, with a karate instructor and an Occupational Therapist specializing in neurodevelopmental disorders, including ADHD.

Adapted karate training

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed by a developmental neurologist with ADHD
  • Age 6-12 years
  • Fluent in Hebrew

You may not qualify if:

  • Comorbidity with another psychiatric or neurological diagnosis, or a developmental syndrome
  • Chronic pain
  • enrolled in a special education system
  • substance abuse (i.e., reporting more than 10 cups of alcohol a week)
  • currently participating in other non-pharmaceutical therapies (e.g., cognitive therapies) started during the past 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv University

Tel Aviv, 6139001, Israel

Location

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivitySelf-Control

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersSocial BehaviorBehavior

Study Officials

  • Tami Bar-Shalita, Proffesor

    Tel Aviv University

    STUDY DIRECTOR
  • Itai Berger, Professor

    Assuta Ashdod Hospital

    STUDY DIRECTOR

Central Study Contacts

Tami Bar-Shalita, Dr.

CONTACT

Yehudit Harris, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
assessors in the RCT will be blind to group allocation.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized controlled crossover trial including two sequences: (1) The experimental group receiving AKT followed by a no-intervention period; (2) A control group receiving no intervention, followed by the AKT intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

January 26, 2026

First Posted

February 24, 2026

Study Start

February 26, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data collected throughout the trial will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
De-identified individual participant data will be made available following publication and for 5 years following publication.
Access Criteria
De-identified individual participant data will be shared with qualified academic and clinical researchers upon reasonable request through researchers email address, following approval of a proposal and execution of a data use agreement.

Locations